ResearcherIstanbul University-CerrahpaşaActive in the last 2 years

Salih Pekmezci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6262-392X; OpenAlex author ID A5067101794. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

Synaptophysin-like-1: A Novel Serum Diagnostic Marker for Pancreatic Ductal Adenocarcinoma Screening, Early Diagnosis, and Prognosis Prediction. Last author DOI 10.3390/jcm14113719 ↗
The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Case-Control Study. Co-author DOI 10.3390/medicina61020168 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yasemin Pekmezci · 2 shared papers, 2025 · strength 0.52
- Paper The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Cas… DOI 10.3390/medicina61020168 ↗
- Paper Synaptophysin-like-1: A Novel Serum Diagnostic Marker for Pancreatic Ductal Adenocarcinoma Screening, Early Diagnosis, … DOI 10.3390/jcm14113719 ↗
Mehmet Velidedeoğlu · 1 shared paper, 2025 · strength 0.27
- Paper The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Cas… DOI 10.3390/medicina61020168 ↗
Sefa Ergün · 1 shared paper, 2025 · strength 0.26
- Paper Synaptophysin-like-1: A Novel Serum Diagnostic Marker for Pancreatic Ductal Adenocarcinoma Screening, Early Diagnosis, … DOI 10.3390/jcm14113719 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.